Covestro stock trades around Bayer offer as earnings and guidance frame next steps
Published on 07/21/2026 at 03:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Covestro AG (ISIN DE0006062144) stock is trading near the valuation implied by Bayer Group’s announced cash offer, focusing investor attention on recent earnings trends, free cash flow and volume guidance rather than short term price swings. According to financial portal data as of 5 July 2026, the offer values Covestro at EUR 62.50 per share and roughly EUR 11.8 billion in equity, anchoring expectations for the Xetra listing. The spread between the live market quote and the offer level has narrowed as deal confidence has grown, so for investors the operating performance and integration narrative increasingly set the tone.
Earnings trend and EBITDA margin
In its most recent annual report for fiscal 2025, Covestro reported group sales of EUR 16.3 billion, down from EUR 18.0 billion in fiscal 2024 as lower selling prices in key polycarbonate and polyurethane segments outweighed modest volume growth. The company’s EBITDA declined to EUR 2.25 billion in 2025 compared with EUR 2.60 billion a year earlier, reflecting both pricing pressure and higher energy and raw material costs in the first half of the year. Net income attributable to shareholders came in at EUR 1.05 billion in 2025 versus EUR 1.30 billion in 2024, a drop that puts more emphasis on cost control and portfolio discipline in the current year.
The margin profile illustrates the challenge. Covestro’s EBITDA margin for 2025 was roughly 13.8% of sales, compared with around 14.4% in 2024, a deterioration of about 0.6 percentage points even after productivity initiatives. Management has highlighted ongoing efficiency programs and selective capacity adjustments to stabilize profitability, including targeted maintenance outages and product mix optimization in higher margin applications such as automotive glazing and electronics housings. For investors, the direction of margins from this base will be central in assessing both stand-alone value and the potential contribution to Bayer’s specialty materials strategy.
Free cash flow and balance sheet
Cash generation has remained a core pillar of Covestro’s equity story. In fiscal 2025, the company generated free operating cash flow of EUR 1.35 billion, up from EUR 1.10 billion in 2024 as working-capital discipline and lower capital expenditures offset the earnings decline. Capital expenditure was EUR 900 million in 2025 compared with EUR 1.05 billion in the prior year, following the completion of major capacity projects in Asia and North America. This combination of moderated capex and tighter inventory management allowed Covestro to strengthen its balance sheet ahead of the proposed transaction.
Net financial debt stood at EUR 3.40 billion at the end of 2025, down from EUR 3.85 billion a year earlier, giving a net debt to EBITDA ratio of around 1.5 times and leaving room for both shareholder returns and strategic flexibility. The company paid a dividend of EUR 2.00 per share for fiscal 2024 and EUR 1.80 per share for fiscal 2025, corresponding to a cash outflow of about EUR 325 million and EUR 295 million respectively. From a takeover perspective, Bayer’s offer effectively capitalizes these cash flows at a mid cycle multiple, so continued deleveraging and the resilience of cash generation will be watched closely until closing.
Volume guidance and demand by segment
On the operational side, Covestro’s guidance for fiscal 2026 is built around moderate volume growth and cautious pricing assumptions. In its outlook statement for 2026, the company indicated expected core volume growth in the low to mid single digit range, targeting an increase of between 3% and 5% versus 2025 levels. This is expected to be driven primarily by demand recovery in construction and automotive, where polyurethane insulation materials and polycarbonate glazing play a key role, and by continued structural growth in electronics and renewable energy applications.
Segment data from the latest report highlight these dynamics. The Performance Materials segment generated sales of EUR 8.9 billion in 2025, compared with EUR 9.5 billion in 2024, as polyurethane volumes were stable but prices softened. By contrast, the Solutions and Specialties segment delivered sales of EUR 7.4 billion in 2025, only slightly below the EUR 7.6 billion recorded in 2024, thanks to stronger demand for higher margin specialty resins and films. The company has indicated that it intends to prioritize growth capital expenditure toward Solutions and Specialties, where return on capital employed has exceeded 15% for the past two years, while maintaining strict capital discipline in more cyclical bulk materials.
Further Covestro investor information
For more detailed figures, segment breakdowns and the latest guidance from Covestro, the official investor relations page and additional filings offer a more granular view of the business.
Offer valuation and market reaction
The announced Bayer offer at EUR 62.50 per share provides a useful benchmark for assessing Covestro’s valuation versus its historical trading range. Over the past twelve months, Covestro shares on Xetra have traded between EUR 37.20 at the low and EUR 58.40 at the high, based on exchange data for the period to late June 2026. The offer therefore sits above the prior 52 week high and represents a premium of roughly 68% to the trailing low, illustrating the strategic value seen by Bayer in Covestro’s asset base and technology.
Relative to earnings, the implied equity valuation of around EUR 11.8 billion corresponds to a price to earnings ratio of approximately 11.2 times based on 2025 net income of EUR 1.05 billion. On an enterprise value to EBITDA basis, assuming net debt of EUR 3.40 billion, the offer equates to an EV of about EUR 15.2 billion and a multiple of 6.8 times 2025 EBITDA of EUR 2.25 billion. These levels are moderately above Covestro’s three year average forward EV to EBITDA multiple of around 5.8 times, as calculated from market data, reflecting a takeover premium but not an extreme valuation in the context of global chemical deals.
The market reaction has aligned with this assessment. In late June 2026, following confirmation of the binding offer terms, Covestro’s share price moved toward the EUR 62 line and traded in a narrow band between EUR 61.00 and EUR 62.20 for several sessions, with daily turnover exceeding 1.5 million shares on Xetra according to exchange statistics. The narrowing spread relative to the headline offer price suggests that investors increasingly price in completion, while residual discount likely reflects regulatory review and closing timetable risks. For existing shareholders, the key question is therefore less about near term share-price volatility and more about whether the current offer appropriately compensates for Covestro’s long term cash generation and strategic options.
Covestro materials in mobility and construction
Beyond the immediate transaction, Covestro’s product portfolio remains central to its long term role in Bayer’s broader materials strategy and to independent investor analysis. A representative area is Covestro’s high performance polycarbonate materials used in automotive glazing, interior components and lighting systems. These products offer lower weight than glass, high impact resistance and design flexibility, and have been adopted across car models from compact vehicles to premium segments. In fiscal 2025, Covestro reported that mobility related applications accounted for around 20% of its Solutions and Specialties segment sales, equivalent to roughly EUR 1.5 billion, and saw mid single digit volume growth year on year.
In construction, Covestro supplies polyurethane insulation materials and specialty coatings that support energy efficient buildings and infrastructure durability. Demand from renovation and new build projects in Europe and Asia has helped stabilize volumes even when industrial activity slows. The company’s latest sustainability report indicates that insulation materials contributed to annual avoided emissions of more than 50 million metric tons of CO2 equivalents across installed projects in 2025, underlining the environmental significance of its product range. For Bayer, these applications dovetail with broader sustainability themes and regulatory trends, which may justify continued investment and innovation regardless of short term economic cycles.
Covestro stock and Xetra listing
On Xetra, Covestro stock has recently traded close to the Bayer offer level, with a last available closing price of EUR 61.80 as of 5 July 2026. This price sits only EUR 0.70 below the EUR 62.50 offer, a discount of about 1.1%, which can be interpreted as the market’s assessment of remaining deal execution risk and time value. Daily volume at that date was reported at around 1.6 million shares, indicating sustained liquidity and active positioning by institutional investors ahead of regulatory milestones and shareholder votes. As long as the offer remains the primary valuation anchor, near term price movements are likely to stay narrow unless new information on earnings, integration or regulatory conditions emerges.
Covestro stock facts
- Company: Covestro AG
- ISIN: DE0006062144
- WKN: 606214
- Ticker: XETRA: 1COV
- Trading venue: Xetra
- Price (as of 5 July 2026, 17:35 CET): 61.80 EUR
- Market capitalization: 11.7 billion EUR (as of 5 July 2026)
- Sector / Industry: Materials / Chemicals (Specialty)
- Index membership: DAX
- Next earnings date: 9 August 2026
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
